Hilde Vanaken, PhD, Eng, MsC

The traditional global-to-local communication model creates fragmented content through sequential adaptation, but a local-first approach using structured data and AI-orchestrated generation can embed stakeholder terminology and preferences from the start, reducing rework while improving clarity and relevance.

AI as an accelerator for data-centric, process-centric, and human-centric clinical research.

Harmonization and value insights are fundamental to bring eConsent to the place it deserves.

Understanding differences in studies, sites, and patients are key to making eConsent successful.

As many countries slowly progress with the “New Normal,” researchers and healthcare providers are assessing digital/virtual approaches that could reinstate clinical trials.

A new SaaS platform for clinical trials, soon available to all pharma companies, aims to automate clinical supply, improve patient compliance and enable better medication adherence.

Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.